HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huijun Wang Selected Research

Erythrokeratodermia Variabilis

11/2022Incompletely penetrant TRPM4-associated progressive symmetric erythrokeratodermia responses to methotrexate.
1/2019Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Huijun Wang Research Topics

Disease

18Neoplasms (Cancer)
03/2022 - 08/2005
13Obesity
05/2022 - 11/2015
10Overweight
05/2022 - 06/2011
9Hypertension (High Blood Pressure)
10/2021 - 05/2012
6Hypercholesterolemia
10/2021 - 06/2015
6Body Weight (Weight, Body)
09/2021 - 05/2014
5Abdominal Obesity
05/2022 - 11/2015
5Lung Neoplasms (Lung Cancer)
01/2022 - 08/2007
5Infections
01/2022 - 01/2016
5Hepatocellular Carcinoma (Hepatoma)
06/2021 - 03/2013
5Neoplasm Metastasis (Metastasis)
03/2021 - 08/2005
5Inflammation (Inflammations)
03/2021 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
04/2022 - 06/2016
4Leukemia
03/2022 - 02/2014
4Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2020
4Dyslipidemias (Dyslipidemia)
10/2021 - 06/2015
4Carcinogenesis
03/2021 - 02/2013
4Cognitive Dysfunction
01/2021 - 01/2019
4Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 02/2014
4Tetralogy of Fallot (Fallot Tetralogy)
01/2017 - 09/2013
3Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2022 - 03/2019
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022 - 10/2014
3Seizures (Absence Seizure)
01/2022 - 08/2018
3Sepsis (Septicemia)
01/2022 - 01/2018
3Deafness (Deaf Mutism)
01/2021 - 04/2013
3Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 02/2013
3Lymphoma (Lymphomas)
02/2017 - 01/2016
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 05/2014
3Carcinoma (Carcinomatosis)
02/2013 - 08/2005
2Erythrokeratodermia Variabilis
11/2022 - 01/2019
2Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
10/2022 - 01/2014
2DiGeorge Syndrome (Syndrome, DiGeorge)
07/2022 - 01/2013
2Insulin Resistance
04/2022 - 01/2020
2Chronic Disease (Chronic Diseases)
12/2021 - 06/2015
2Hepatic Encephalopathy
06/2021 - 03/2021
2Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 12/2020
2Diarrhea
01/2021 - 10/2019
2Stroke (Strokes)
01/2021 - 05/2016
2Necrosis
01/2021 - 07/2003
2Proteinuria
01/2020 - 02/2017
2Hypertriglyceridemia
11/2019 - 11/2018
2Rheumatoid Arthritis
10/2019 - 01/2005
2Poisoning
02/2018 - 07/2014
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2017
2Congenital Microtia
02/2017 - 04/2013
2Chromosome Aberrations (Chromosome Abnormalities)
01/2017 - 06/2014

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2003
6CholesterolIBA
10/2022 - 06/2015
6DNA (Deoxyribonucleic Acid)IBA
07/2022 - 02/2011
6oxidized low density lipoproteinIBA
05/2022 - 11/2015
6Biological ProductsIBA
10/2021 - 09/2013
6Dietary CholesterolIBA
11/2019 - 06/2015
5Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2018
5SodiumIBA
01/2022 - 02/2014
5Pharmaceutical PreparationsIBA
01/2021 - 01/2017
4MagnesiumIBA
05/2022 - 07/2017
4Methamphetamine (Desoxyn)FDA LinkGeneric
01/2021 - 05/2014
4MicroRNAs (MicroRNA)IBA
05/2013 - 03/2012
3AcidsIBA
01/2022 - 05/2014
3EnzymesIBA
01/2022 - 03/2021
3ORALIT (ORS)IBA
01/2022 - 02/2016
3CarbohydratesIBA
12/2021 - 01/2019
3Biomarkers (Surrogate Marker)IBA
12/2021 - 02/2013
3HDL CholesterolIBA
03/2021 - 01/2019
3CalciumIBA
09/2020 - 12/2018
3PotassiumIBA
01/2020 - 02/2014
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 06/2005
3TabletsIBA
01/2020 - 10/2019
3Indicators and Reagents (Reagents)IBA
11/2018 - 01/2013
3Messenger RNA (mRNA)IBA
01/2018 - 09/2013
3tissue-factor-pathway inhibitor 2 (PP5)IBA
09/2013 - 01/2012
2LipidsIBA
05/2022 - 01/2020
2Blood Glucose (Blood Sugar)IBA
05/2022 - 05/2022
2Chimeric Antigen ReceptorsIBA
03/2022 - 01/2020
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2022 - 01/2012
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2022 - 02/2019
2Transaminases (Aminotransferases)IBA
01/2022 - 12/2020
2LDL Lipoproteins (beta Lipoproteins)IBA
10/2021 - 11/2019
2MicronutrientsIBA
09/2021 - 09/2020
2Hemoglobins (Hemoglobin)IBA
01/2021 - 07/2017
2Protein Kinases (Protein Kinase)IBA
01/2021 - 06/2016
2LDL CholesterolIBA
11/2020 - 01/2019
2ProteomeIBA
10/2020 - 10/2020
2Dietary SodiumIBA
01/2020 - 02/2014
2Interleukin-17 (Interleukin 17)IBA
01/2020 - 01/2016
2SteroidsIBA
01/2020 - 11/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 08/2007
2HDL LipoproteinsIBA
11/2019 - 11/2018
2Triglycerides (Triacylglycerol)IBA
03/2019 - 01/2019
2Interleukin-10 ReceptorsIBA
01/2018 - 01/2017
2Apolipoproteins E (ApoE)IBA
02/2017 - 09/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017 - 06/2016
2Small Interfering RNA (siRNA)IBA
01/2017 - 08/2007

Therapy/Procedure

11Therapeutics
03/2022 - 04/2015
9Drug Therapy (Chemotherapy)
09/2021 - 03/2009
3General Anesthesia
01/2022 - 11/2019
3Precision Medicine
01/2022 - 01/2019
2Immunotherapy
03/2022 - 12/2021
2Length of Stay
01/2022 - 01/2022
2Transplantation
01/2018 - 05/2014